Advertisements



Amgen"s Repatha "significantly reduced" LDL-C, non-HDL-C in Type 2 diabetes

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 23rd, 2018

Amgen"s Repatha Reduces Bad Cholestrol in Type II Diabetes

Amgen's (AMGN) Repatha signi.....»»

Category: smallbizSource: nytJun 25th, 2018

Tuberculosis Vaccine Could Reverse Type 1 Diabetes, Study Shows

Just two jabs reverses diabetes even in people who have had the Type 1 form for decades. The causes of Type 1 diabetes can be significantly reversed over several years with just two injections of a common .....»»

Category: europeSource: fortuneJun 21st, 2018

Novo Nordisk"s Ozempic Lowers Risk of Cardiovascular Events (revised)

Novo Nordisk (NVO) announces post hoc results from SUSTAIN 6 study demonstrating that Ozempic consistently reduces the risk of major cardiovascular (CV) events across type II diabetes population. Novo Nordisk A/S NVO announce.....»»

Category: worldSource: nytSep 4th, 2018

The secret to lowering stress just might be giving yourself flowers

A new study from the University of North Florida found that women who received flowers experienced significantly reduced stress levels compar.....»»

Category: topSource: businessinsiderAug 27th, 2018

Nemours finishes historic children"s diabetes research

As part of a research project conducted by four institutions across the nation, one Jacksonville hospital is taking part in the next big break in type 1 diabetes treatment. Researchers at Nemours Children's Specialty Care on the Southbank of the S.....»»

Category: topSource: bizjournalsAug 15th, 2018

Amgen quarterly profit beats Wall Street view on new product sales

Amgen Inc on Thursday reported a better-than-expected second quarter profit and raised its full-year forecast, as growth of newer drugs like cholesterol fighter Repatha and osteoporosis drug Prolia offset weakness in older products......»»

Category: topSource: reutersJul 26th, 2018

‘Clash of Clans’ TH12 Balance Update Offers Major Cuts to In-Game Timers

“Clash of Clans” building and research timers have been significantly reduced in the game’s latest update......»»

Category: topSource: newsweekJun 26th, 2018

Merck (MRK) Presents New Data from Januvia Diabetes Studies

Merck (MRK) produces new data from two studies on type II diabetes medicine Januvia (sitagliptin), which supports the drug's clinical profile. Merck & Co., Inc MRK presented new data from two studies, evaluating its type II di.....»»

Category: dealsSource: nytJun 25th, 2018

Study of Lilly"s Humulin R U-500 shows improved response in type 2 diabetes

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 25th, 2018

Merck presents new data from comparative trials in Type 2 diabetes

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 24th, 2018

Eli Lilly"s Trulicity shows promise in delivering efficacy in type 2 diabetes

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 23rd, 2018

Oppenheimer: After FDA Approval Of Tandem"s Insulin Pump, Investor Focus Will Shift To 2018 Opportunities

Late Thursday, Tandem Diabetes Care Inc (NASDAQ: TNDM) announced FDA approval of its t:slim X2 insulin pump with Basal-IQ for Type 1 diabetes patients, which is planned for an August launch. Latest Ratings for TND.....»»

Category: blogSource: benzingaJun 22nd, 2018

Type 1 Diabetes: Tuberculosis Vaccine Could Offer “Major Advancement” in Treatment

“I hate the word ‘cure’ because it means something different to everybody,” one of the researchers said. “But I think it’s a major advancement.... It has simplicity.”.....»»

Category: topSource: newsweekJun 22nd, 2018

Type 1 Diabetes: Tuberculosis Vaccine Could Offer “Major Advancement” In Treatment

“I hate the word ‘cure’ because it means something different to everybody,” one of the researchers said. “But I think it’s a major advancement...it has simplicity.”.....»»

Category: topSource: newsweekJun 22nd, 2018

Novo Nordisk"s (NVO) Oral Ozempic Positive in Diabetes Study

Novo Nordisk (NVO) announces positive headline results of two phase III studies PIONEER oral formulation of Ozempic (semaglutide) as a treatment for adults with type II diabetes. Novo Nordisk NVO announced positive headline results o.....»»

Category: personnelSource: nytJun 21st, 2018

Cutting-edge tech makes diabetes management easier (and less painful) than ever

Roughly 1.25 million Americans have Type 1 diabetes.....»»

Category: topSource: latimesJun 7th, 2018

Almost a quarter of the world’s population will be obese by 2045

New research using WHO data says 1 in 8 people will have type 2 diabetes unless more countries take action......»»

Category: topSource: marketwatchMay 24th, 2018

Amgen receives EC approval for Repatha to prevent heart attack, stroke

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 16th, 2018

What"s Your Blood Type? It Could Increase the Risk of Death From Serious Injury Significantly

Serious injury patients with this blood type died at nearly three times the rate of patients with others......»»

Category: topSource: newsweekMay 2nd, 2018

Alzheimer’s Disease Risk Significantly Reduced in Skin Cancer Survivors, but We Don’t Know Why

It's not yet clear why skin cancer survivors had a dramatically reduced risk of developing Alzheimer's disease......»»

Category: topSource: newsweekApr 20th, 2018